Review Article Genetics of coronary artery disease: focus on genome-wide association studies
Linnea M. Baudhuin
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Received February 27, 2009; accepted March 5, 2009; available online March 5, 2009
Abstract: With the advent of the genome-wide association (GWA) study, a promising new avenue for identifying genetic markers for complex diseases like coronary artery disease (CAD) has been opened. This avenue, however, is not without challenges and limitations, including the need for carefully designed and executed studies and the risk of false positive associations. Nonetheless, new markers have been identified through such studies that could potentially revolutionize the ways that individuals with CAD are identified and managed.(AJTR902004).
Address all correspondence to: Linnea M. Baudhuin, Ph.D., Department of Laboratory Medicine and Pathology Mayo Clinic, 200 First St SW Rochester, MN 55905 Tel: (507) 284-2511, Fax: (507) 266 4176 E-mail: baudhuin.linnea@mayo.edu